Latest Stories
Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics
Veterinary Cancer Society Annual Conference 2024
Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning
Veterinary Cancer Society Annual Conference 2024
Decoding Feline Lymphoma: From Diagnosis to Prognosis
Veterinary Cancer Society Annual Conference 2024
Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models
Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support
World Veterinary Cancer Congress 2024
Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results
World Veterinary Cancer Congress 2024
AI-driven Personalized Medicine for Cancer Care
Precision Medicine World Conference 2024
Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions
Veterinary Cancer Society Annual Conference 2023
Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine
Veterinary Cancer Society Annual Conference 2023
Impact of AI on clinical practice and outcome
Veterinary Cancer Society Annual Conference 2023
Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen
Veterinary Cancer Society Annual Conference 2023
ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care
Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Reinventing precision medicine: from dogs to humans
Precision Medicine World Conference 2023
Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS
Veterinary Cancer Society Annual Conference 2022
Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma
Veterinary Cancer Society Mid-Year Conference 2022
Precision medicine for pet cancer care
Animal Health, Nutrition and Technology Innovation Europe 2022